SCHEMBL7969606

SCHEMBL7969606

CCCC(CC(Cl)C(F)(F)C(F)(F)F)S(=O)(=O)C(CCC)CC(Cl)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15263002 0.85
SCHEMBL7946802 0.76
SCHEMBL15263172 0.76 CA12 (0.30)
SCHEMBL15263354 0.75 CA12 (0.32)
SCHEMBL15263455 0.75
SCHEMBL7957703 0.72
SCHEMBL14775191 0.69
SCHEMBL14775603 0.69 CA12 (0.33)
SCHEMBL15153129 0.68 CA1 (0.42)
SCHEMBL9995600 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130252890-A1 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-26 US disclosed
US-6288051-B1 ESTROGEN-DEPENDENT BREAST CANCER TREATMENT SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed